Rod Porter

bio wrapper

headshot column

bio sketch column

An independent medicinal chemistry consultant since 2008, Rod Porter has been an advisor to Wellcome Trust Seeding Drug Discovery initiative (SDDI) projects, academic groups and subject-matter experts on hit identification and moving from lead optimisation to preclinical candidates. He gained experience over 25 years at GlaxoSmithKline and legacy companies working on a range of novel targets with a particular focus on the central nervous system.